Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Texas
Manufacturing
Lilly weighs Houston as option for new $5.9B API facility
Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion API facility in Houston, according to a state filing.
Fraiser Kansteiner
May 19, 2025 10:21am
Compounder in Lilly lawsuit hit with FDA warning letter
Apr 24, 2025 8:20am
AZ tacks on $2B to its investment in US manufacturing, R&D
Nov 12, 2024 10:10am
IntraBio snags FDA nod in rare disease just days after Zevra
Sep 25, 2024 9:50am
Asahi Kasei's CDMO Bionova branches out into plasmid DNA
Jun 3, 2024 11:36am
Takeda shells out $42M to settle Medicaid fraud claims in Texas
Aug 9, 2023 11:41am
